SCHEMBL13005285

SCHEMBL13005285

CCCCCc1ccc(-c2ccc(-c3ccc4c5c(c(C(=O)OCC)cc4c3)C=CC(c3ccccc3)(c3ccc(N4CCC(CCCCC)CC4)cc3)O5)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.33
S1PR1 P21453 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
CTSD P07339 2/20 0.31
RARB P10826 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAOA P21397 2/20 0.31
ADRB2 P07550 1/20 0.31
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
MAOB P27338 1/20 0.31
SOAT1 P35610 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005273 0.92 SIRT2 (0.38) DGAT1S1PR1RARBSIRT2LMNA
SCHEMBL13005275 0.91 SIRT2 (0.39) DGAT1S1PR1RARBSIRT2LMNA
SCHEMBL18961302 0.89 SIRT2 (0.35) DGAT1SIRT2LMNAMAPTNPSR1
SCHEMBL16474339 0.89 SIRT2 (0.37) S1PR1RARBSIRT2LMNAMAPT
SCHEMBL13005280 0.87 SIRT2 (0.37) SIRT2MAPTMEN1KMT2A
SCHEMBL13005281 0.86 S1PR1 (0.35) DGAT1S1PR1RARBSIRT2MAPT
SCHEMBL13005279 0.85 S1PR1 (0.35) DGAT1S1PR1RARBSIRT2MAPT
SCHEMBL16474337 0.85 SIRT2 (0.36) DGAT1S1PR1SIRT2LMNAMAPT
SCHEMBL16474342 0.85 RARB (0.38) RARBKDM4E
SCHEMBL18961305 0.85 SIRT2 (0.36) S1PR1SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED (US) 2014-07-17 US disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140197361-A1 DICHROIC-PHOTOCHROMIC 2H-NAPHTHO[1,2-b]PYRAN COMPOUNDS AND DEVICES NR0B2, NR0B1, DHCR24 DGAT1 3619/4885S1PR1 630/4885FFAR4 1657/4885
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES NR0B2, NR0B1, NR2E3 DGAT1 2891/4885S1PR1 807/4885FFAR4 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.